Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 62 recruiting now full pipeline #74 of 28,707 conditions

Insomnia: full-pipeline trial registry

62 of 152 indexed Insomnia trials are currently recruiting.

Corpus placement: #74 of 28,707 conditions by registered trial count.

152 US clinical trials · 62 currently recruiting · #74 of 28,707 conditions by registered trial count

Insomnia: 152 US clinical trials tracked, 62 recruiting.

Insomnia is the subject of 152 registered US clinical trials on ClinicalTrials.gov, 62 of them currently open to new participants. 17 are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most active sponsor is VA Office of Research and Development, running 9 of these trials.

Enrollment posture brief

Registry condition insomnia

OPEN 62 | RECR 41% | LATE 17 | EARLY 21 | RANK #74 | SPON 9

Nearest open-share peer: Brain Injuries, Traumatic (41% recruiting · 22 trials)

Cervical Cancer48.3%Sleep48%Stress41.8%Insomnia (this)41%Atopic Dermatitis36.4%
Open-enrollment share among volume-matched conditions near Insomnia

Insomnia lists 62 open slots (41% of 152 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Insomnia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Insomnia is recruiting above its size-band peers.

    62 of 152 indexed trials (40.8%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Insomnia trials is spread across many organizations.

    VA Office of Research and Development accounts for 9 of 152 trials (5.9%). 86 distinct sponsors appear on at least one study for this condition label.

  3. Typical Insomnia enrolment sits around 80 participants.

    Median target enrolment is 80 among the 152 trials that report a genuine target (sentinel values excluded). 85 of those (55.9%) plan for fewer than 100 participants.

  4. Insomnia research is mostly interventional.

    147 interventional and 5 observational studies make up this index (96.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 15Phase 216Phase 35Phase 412

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 16
Phase 3 5
Phase 4 12

Named interventions

Most-linked intervention names on Insomnia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
10 trials
Placebo Other
8 trials
Cognitive Behavioral Therapy for Insomnia Behavioral
7 trials
CBT-I Behavioral
5 trials
Suvorexant Drug
5 trials
Cognitive Behavioral Therapy for Insomnia (CBT-I) Behavioral
5 trials
Eszopiclone Drug
4 trials
Trazodone Drug
4 trials

US sites by state

Facility locations filed on Insomnia trials. A trial with sites in several states counts in each.

California 25 trials
Massachusetts 22 trials
Pennsylvania 14 trials
Michigan 14 trials
New York 12 trials
Florida 12 trials
Maryland 11 trials
North Carolina 9 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Insomnia page

152 registered trials, 62 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Insomnia condition card totals 152 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.